Handbook of the law of bills and notes [electronic resource] /

Reproduction of original from Harvard Law School Library.

Hospitalization for fishermen : Hearing before the Committee on the Merchant Marine and Fisheries, House of Representatives, Seventy-seventh Congress, first session, on H.R. 84, H.R. 5051, and H.R. 5130, bills to extend the benefits of the United States Public Health Service to fishermen, and for other purposes. July 8, 1941.

Schuyler O. Bland, chairman.

Report of the Select committee on bills nos. 2 and 3 in reference to safety on railways. Session 1897.

Signed: George E. Casey, chairman.

Court of commerce, railroad rates, etc. Hearing before the Committee on interstate commerce United States Senate on the bills S. 3776 and S. 5106, February 3 and 4 [to February 18] 1910 ...

Stephen B. Elkins, chairman.

Vetoes by the Governor of Bills Passed by the Legislature

1942 Issued Only In the Laws of the General Assembly

Calendar Showing Complete Record and Final Disposition of All Bills, Resolutions, Memorials, Etc

Mode of access: Internet.

Calendar Showing Complete Record and Final Disposition of All Bills, Resolutions, Memorials, Etc

Superseded by Oregon. Legislative Assembly. Legislative Calendar, After 1957

The law of bills and notes,

"Table of cases": p. xiii-xx

Hearings before a subcommittee on the Committee on interstate and foreign commerce of the House of representatives, Sixty-third Congress, second session, on bills proposing to amend the Carmack amendment. September 24, 25, and 30, 1914.

Mode of access: Internet.

Index of all Senate and Assembly bills, constitutional amendments, joint and concurrent resolutions and House resolutions and list of code sections affected as of June 1, 1949.

Mode of access: Internet.

Rehabilitation act of 1972. Hearings, Ninety-second Congress, second session, H.R. 8395 ... and related bills.

Hearings held May 15-June 6, 1972.

National Health Service Corps act of 1970. Hearing, Ninety-first Congress, second session, on S. 4106 and related bills. August 28, 1970.

Mode of access: Internet.

Federal metal and nonmetallic mine safety act. Hearings before the Select Subcommittee on Labor of the Committee on Education and Labor, House of Representatives, Eighty-ninth Congress, first session, on H. R. 6961 and similar bills, a bill to promote health and safety in metal and nonmetallic mineral industries, and for other purposes.

Adam C. Powell, chairman.

Digest of Council bills in ... session /

WI docs no.: LEG.1/4:1951-

Pro-matrix metalloproteinase-2 transfection increases orthotopic primary growth and experimental metastasis of MDA-MB-231 human breast cancer cells in nude mice

The ability to activate pro-matrix metalloproteinase (pro-MMP)-2 via membrane type-MMP is a hallmark of human breast cancer cell lines that show increased invasiveness, suggesting that MMP-2 contributes to human breast cancer progression. To investigate this, we have stably transfected pro-MMP-2 into the human breast cancer cell line MDA-MB-231, which lacks MMP-2 expression but does express its cell surface activator, membrane type 1-MMP. Multiple clones were derived and shown to produce pro-MMP-2 and to activate it in response to concanavalin A. In vitro analysis showed that the pro-MMP-2-transfected clones exhibited an increased invasive potential in Boyden chamber and Matrigel outgrowth assays, compared with the parental cells or those transfected with vector only. When inoculated into the mammary fat pad of nude mice, each of the MMP-2-tranfected clones grew faster than each of the vector controls tested. After intracardiac inoculation into nude mice, pro-MMP-2-transfected clones showed a significant increase in the incidence of metastasis to brain, liver, bone, and kidney compared with the vector control clones but not lung. Increased tumor burden was seen in the primary site and in lung metastases, and a trend toward increased burden was seen in bone, however, no change was seen in brain, liver, or kidney. This data supports a role for MMP-2 in breast cancer progression, both in the growth of primary tumors and in their spread to distant organs. MMP-2 may be a useful target for breast cancer therapy when refinement of MMP inhibitors provides for MMP-specific agents.